OCD Clinical Trial
Official title:
Randomized Controlled Meditation Trial for Treating OCD Comparing Kundalini Yoga Meditation Versus the Relaxation Response
The trial objective is to compare two very different meditation protocols (Kundalini Yoga and Relaxation Response meditation techniques) to help the OCD treatment.
The proposed trial comparing the two different meditation protocols is expected to have two phases: 0-month to 4.5-month period where we compare the Kundalini Yoga protocol with Relaxation Response meditation technique, both on the primary efficacy variable using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and some if not most of the secondary variables using The Dimensional Yale-Brown Obsessive Compulsive Scale (DY-BOCS), Clinical Global Impressions (CGI), Profile of Mood States (POMS), Beck Anxiety Inventory (Beck-A), Beck Depression Inventory (Beck-D), and SF-36 Health Status Questionnaire (SF36). Participants will go to the hospital once a week for a 1,5 hour meditation class.After 4.5-months, all patients will be evaluated and merged together into a single group. Patients will then receive 09 to 12 more months of the meditation protocol. The investigators are expecting to recruit 50 to 60 patients to start. Patients will be blinded to the content of the protocol in the other group at baseline and until one group shows greater efficacy on the primary efficacy variable. The intake physician will be blinded to the treatment groups of the patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00215137 -
Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder
|
Phase 2 | |
Recruiting |
NCT06050369 -
Objective Characterizatoion of Repetitive Behaviors
|
N/A | |
Recruiting |
NCT06347978 -
Personalized DBS for OCD Guided by Stereoencephalography Mapping
|
N/A | |
Withdrawn |
NCT03926546 -
Individual Versus Group Exposure With Response Prevention (ERP) for the Treatment of Obsessive Compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT05712057 -
Neurostimulation Versus Therapy for Problems With Emotions
|
N/A | |
Not yet recruiting |
NCT03313622 -
Locating Biomarkers in OCD Through Behavioral Tasks
|
||
Withdrawn |
NCT03842345 -
DELPhI Evaluation of Psychiatric Conditions
|
||
Completed |
NCT02866422 -
Development of an Instrument That Monitors Behaviors Associated With OCD
|
N/A | |
Recruiting |
NCT04904952 -
Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients
|
N/A | |
Completed |
NCT05981690 -
Therapist Guided, Parent-led, Cognitive Behavioural Therapy (CBT) for Preadolescent Children With Obsessive Compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT02500888 -
Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT06244121 -
Effect of Pyridoxine as Add-on Therapy in OCD Patients
|
N/A | |
Recruiting |
NCT05580614 -
Paired tVNS With ERP in OCD
|
N/A | |
Active, not recruiting |
NCT03511534 -
Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT05624528 -
A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
|
Phase 2 | |
Recruiting |
NCT05881356 -
Discovering Factors in the Clinical Study Journey of Patients With OCD
|
||
Recruiting |
NCT05359562 -
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
|
N/A | |
Recruiting |
NCT03459456 -
Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
|
||
Active, not recruiting |
NCT05930912 -
Psychiatric Orders in Psychoanalytic Treatment of ASD
|